The deal is a non-exclusive agreement and the companies were selected through an international bidding process. The arrangement includes the transfer of technology dealing with the manufacture, testing, packaging, storage and handling of the drug's active ingredient. The drug is a second line antiretroviral for patients who have developed a resistance to more common drugs. Peter Dolan, the chief executive of BMS, said the company has taken a broad-based approach to addressing the Aids crisis, which included providing Aids medicines at no-profit prices.
South African and Indian firms win aids drug license
Aspen Pharmacare, South Africa, and Emcure Pharmaceuticals, India, have won a royalty-free licence agreement for the generic of Bristol-Myers Squibb's (BMS) antiretroviral drug Atazanavir, which earned BMS $696 million in sales in the US last year. Atazanavir is known as Reyataz in the US.
May 31, 2007
Recommended
Recommended
Machinery Basics
Break out of the ordinary: see what’s new in packaging & processing!
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this September to experience a breakthrough in packaging and processing.
REGISTER NOW AND SAVE
Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
